Skip to main content

Pediatric Acute Lymphoblastic Leukemia (ALL) Profile, FISH

CPT

Contact CPT coding department at 800-222-7566, ext 6-8400.

Synonyms
  • Acute Lymphocytic Leukemia (ALL), Pediatric
  • Share
  • Print
  • Updated on 03/31/2025

Test Details

Methodology

Fluorescence in situ hybridization (FISH)

Result Turnaround Time

3 - 5 days

Turnaround time is defined as the usual number of days from the date of pickup of a specimen for testing to when the result is released to the ordering provider. In some cases, additional time should be allowed for additional confirmatory or additional reflex tests. Testing schedules may vary.

Related Documents

Test Includes

Fluorescence in situ hybridization (FISH) for acute lymphoblastic leukemia (ALL), targeting rearrangement of BCR-ABL, TCF3, KMT2A (MLL), ETV6/RUNX1, and numerical changes of 4, 10, 17, and CDKN2A deletion.

Use

This test is a diagnostic and prognostic test for acute lymphoblastic leukemia in the pediatric population. Detection rate is improved from 50% with a chromosome study to 90% with FISH.

Diagnostic and prognostic test for acute lymphoblastic leukemia in the pediatric population; detection rate is improved from 50% with a chromosome study to 90% with FISH

This test is a diagnostic and prognostic test for acute lymphoblastic leukemia in the pediatric population. Detection rate is improved from 50% with a chromosome study to 90% with FISH.

Special Instructions

Indicate pertinent clinical diagnosis and previous cytogenetic studies on the test request form.

Limitations

Molecular mutations or chromosomal alterations not targeted by the probe included in this profile will not be detected. 

This test was developed and its performance characteristics determined by Labcorp. It has not been cleared or approved by the Food and Drug Administration.

Molecular mutations or chromosomal alterations not targeted by the probes included in this profile will not be detected.

Molecular mutations or chromosomal alterations not targeted by the probe included in this profile will not be detected. 

This test was developed and its performance characteristics determined by Labcorp. It has not been cleared or approved by the Food and Drug Administration.

Specimen Requirements

Specimen

Whole blood, bone marrow, CSF, fixed-cell pellet from a cytogenetic analysis, slide with metaphase and/or interphase nuclei or bone marrow touch preparation slides are acceptable for testing.

Blood, bone marrow, CSF, fixed-cell pellet from a cytogenetic analysis, slide with metaphase and/or interphase nuclei or bone marrow touch preparation slides are acceptable for testing.

Whole blood, bone marrow, CSF, fixed-cell pellet from a cytogenetic analysis, slide with metaphase and/or interphase nuclei or bone marrow touch preparation slides are acceptable for testing.

Volume

5 mL whole blood (pediatric), 3 mL bone marrow, fixed-cell pellet from a cytogenetic analysis, 12 slides with metaphase and/or interphase nuclei or 12 touch preparation slides

5 mL blood (pediatric), 3 mL bone marrow, fiexed-cell pellet from a cytogenetic analysis, 12 slides with metaphase and/or interphase nuclei or 12 touch preparation slides.

5 mL whole blood (pediatric), 3 mL bone marrow, fixed-cell pellet from a cytogenetic analysis, 12 slides with metaphase and/or interphase nuclei or 12 touch preparation slides

Minimum Volume

1 mL whole blood (pediatric), 1 mL bone marrow, fixed-cell pellet from cytogenetic analysis, 6 slides with metaphase and/or interphase nuclei or 6 touch preparation slides (Note: Minimum volumes may not allow for repeat testing.)

1 mL blood (pediatric), 1 mL bone marrow, fixed-cell pellet from a cytogenetic analysis, 6 slides with metaphase and/or interphase nuclei or 6 touch preparation slides. (Note: Minimum volumes may not allow for repeat testing.)

1 mL whole blood (pediatric), 1 mL bone marrow, fixed-cell pellet from cytogenetic analysis, 6 slides with metaphase and/or interphase nuclei or 6 touch preparation slides (Note: Minimum volumes may not allow for repeat testing.)

Container

Green-top (sodium heparin) tube; pediatric Vacutainer® is optimal or lavender-top (EDTA) tube (suboptimal). For samples with shared karyotype (510999) and any FISH study in the same tube, EDTA is not recommended due to the growth inhibition in cell culture. Adjust tube size to sample volume to avoid heparin toxicity.

Green-top (sodium heparin) tube; pediatric Vacutainer® is optimal or lavender-top (EDTA) tube (suboptimal). Adjust tube size to sample volume to avoid heparin toxicity.

Green-top (sodium heparin) tube; pediatric Vacutainer® is optimal or lavender-top (EDTA) tube (suboptimal). For samples with shared karyotype (510999) and any FISH study in the same tube, EDTA is not recommended due to the growth inhibition in cell culture. Adjust tube size to sample volume to avoid heparin toxicity.

Collection Instructions

Utilize sterile technique and Labcorp transport kits when possible.

Transport to the testing laboratory at room temperature, use of a cool pack or a LabCorp transport kit is acceptable. Do not allow samples to overheat or freeze.

Utilize sterile technique and Labcorp transport kits when possible.

Storage Instructions

Transport to the testing laboratory at room temperature; use of a cool pack or a Labcorp transport kit is acceptable. Do not allow samples to overheat or freeze.

Maintain the specimen at either room temperature or refrigerate. Do not freeze.

Transport to the testing laboratory at room temperature; use of a cool pack or a Labcorp transport kit is acceptable. Do not allow samples to overheat or freeze.

Causes for Rejection

Broken Vacutainer®; broken or stained slides; paraffin blocks; paraffin slides; decalcified bone cores; frozen specimen; quantity not sufficient for analysis

LOINC® Map

Order Code Order Code Name Order Loinc Result Code Result Code Name UofM Result LOINC
510324 FISH Pediatric ALL Oncology 510709 Specimen Type 31208-2
510324 FISH Pediatric ALL Oncology 510687 Cells Counted 62361-1
510324 FISH Pediatric ALL Oncology 510688 Cells Analyzed 62360-3
510324 FISH Pediatric ALL Oncology 510689 FISH Result 48674-6
510324 FISH Pediatric ALL Oncology 510326 Interpretation 50398-7
510324 FISH Pediatric ALL Oncology 510327 Director Review: 48672-0
510324 FISH Pediatric ALL Oncology 512123 PDF 11502-2
Order Code510324
Order Code NameFISH Pediatric ALL Oncology
Order Loinc
Result Code510709
Result Code NameSpecimen Type
UofM
Result LOINC31208-2
Order Code510324
Order Code NameFISH Pediatric ALL Oncology
Order Loinc
Result Code510687
Result Code NameCells Counted
UofM
Result LOINC62361-1
Order Code510324
Order Code NameFISH Pediatric ALL Oncology
Order Loinc
Result Code510688
Result Code NameCells Analyzed
UofM
Result LOINC62360-3
Order Code510324
Order Code NameFISH Pediatric ALL Oncology
Order Loinc
Result Code510689
Result Code NameFISH Result
UofM
Result LOINC48674-6
Order Code510324
Order Code NameFISH Pediatric ALL Oncology
Order Loinc
Result Code510326
Result Code NameInterpretation
UofM
Result LOINC50398-7
Order Code510324
Order Code NameFISH Pediatric ALL Oncology
Order Loinc
Result Code510327
Result Code NameDirector Review:
UofM
Result LOINC48672-0
Order Code510324
Order Code NameFISH Pediatric ALL Oncology
Order Loinc
Result Code512123
Result Code NamePDF
UofM
Result LOINC11502-2